Welcome to our dedicated page for Mobilicom SEC filings (Ticker: MOB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Mobilicom's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Mobilicom's regulatory disclosures and financial reporting.
Mobilicom Limited amended its at-the-market (ATM) sales agreement with ThinkEquity, increasing the maximum aggregate offering price under its Form F-3 shelf to $37,000,000, as reflected in a new prospectus supplement dated October 29, 2025.
The company may sell Ordinary Shares and ADSs (each ADS represents 275 Ordinary Shares) from time to time through Nasdaq or other permitted methods under Rule 415. To date, it has sold 1,842,610 ADSs for net proceeds of approximately $9.7 million under the prior ATM authorization.
Mobilicom Limited reports that it held a Special General Meeting of Shareholders on October 9, 2025, where shareholders voted on a proposal described in a previously furnished proxy statement. The proposal received the required majority and was approved.
The company also states that this Form 6-K is incorporated by reference into its existing registration statements on Form S-8 (File Nos. 333-284265 and 333-289762) and Form F-3 (File No. 333-274929), making this information part of those registration statements from the submission date.
Mobilicom Limited reported that its Board of Directors appointed Liat Caner as a director, effective September 29, 2025. She will also serve on the company’s Audit and Risk Committee and Remuneration and Nomination Committee, giving her a direct role in financial oversight and executive pay decisions.
Caner brings more than 20 years of experience as a financial leader at public, venture-backed, and startup companies, including serving as Chief Financial Officer at InfinityLabs R&D since 2022 and previously at Bactochem group companies. The Board determined that she is an independent director under Securities and Exchange Commission and Nasdaq rules and qualifies as an “audit committee financial expert”, signaling strong financial expertise on the Board.
Mobilicom Limited filed an amended foreign issuer report to correct a mistake in an earlier notice about its upcoming Special General Meeting of Shareholders. The meeting is scheduled for October 9, 2025, at 4:30 p.m. Melbourne, Australia time.
The amendment clarifies that for holders of American Depositary Shares, the record date is September 18, 2025. ADS holders of record at the close of business on that date will be entitled to vote at the meeting and at any postponements or adjournments. The report also attaches and incorporates the proxy materials and is made part of the company’s existing Form S-8 and Form F-3 registration statements.
Mobilicom Limited has furnished a Form 6-K to distribute proxy materials for a Special General Meeting of Shareholders. The meeting is scheduled for Friday, October 9, 2025, at 4:30 p.m. (Melbourne, Australia time).
Holders of American Depositary Shares will be entitled to vote at the meeting if they hold ADSs at the close of business on October 7, 2025, which is the record date for ADS holders. The filing also states that this report is incorporated by reference into Mobilicom’s existing registration statements on Form S-8 and Form F-3.